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26a Sunday, February 3, 2013(c-type) inactivated state, is coupled to the opening and closing of the activation
(intracellular) gate. Opening the activation gate by applying an external stim-
ulus results in a transient current before the selectivity filter undergoes a spon-
taneous transition toward the non-conductive inactivated conformation that
blocks the passage of ionic current through the channel. Only after closing
the activation gate by removing the external stimulus will the selectivity filter
return back to its original conductive conformation, resetting the filter so that it
may once again pass current. While it is thought that recovery from the non-
conductive inactivated state involves subtle conformational changes of the se-
lectivity filter, the reason why this process can take up to several seconds,
which is extremely slow on the molecular timescale, is not understood. Our re-
sults from a series of MD simulations reveal the selectivity filter is sterically
locked in the inactive conformation for more than 15 microseconds by 12 bur-
ied water molecules, 3 for each subunit, that are strongly bound behind the fil-
ter. Even the presence of a few of these buried waters appears to lock the
selectivity filter in the inactive conformation, blocking the filter from returning
to a conductive conformation until the buried waters spontaneously vacate each
subunit. Such an event would be rare, stretching the process of recovery to the
timescale of seconds. To validate this mechanism, experiments were conducted
where an osmotic stress was applied on the extracellular side of the channel to
decrease the probability of waters occupying the cavities located behind the fil-
ter. As predicted, this accelerated the rate of recovery from slow inactivation.
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The nature of the signaling complex between G protein-coupled receptors
(GPCRs) and G proteins remains unclear. GPCRs can exist as oligomers, yet
monomers can activate G proteins when reconstituted in nanodiscs; the interac-
tion with the G protein often is considered transient, yet some evidence sug-
gests that the RG complex remains intact during signaling. Two classes of
sites typically are observed in the binding of agonists to GPCRs in natural
membranes, and guanylyl nucleotides such as GMP-PNP effect an apparent in-
terconversion from higher (KH) to lower affinity (KL) without affecting affinity
per se. We have examined three models of a stable RG complex in which the
M2 muscarinic receptor is fused to Gai1 via different linking sequences. Each
fusion protein was expressed in Sf9 cells and characterized as an oligomer in
digitonin-solubilized preparations, as a purified monomer in solution, and as
an oligomer reconstituted in phospholipid vesicles. In the oligomeric state,
the agonist oxotremorine-M recognized two classes of sites; GMP-PNP pro-
gressively increased the low-affinity fraction without affecting KH or KL. In
the monomeric state, oxotremorine-M similarly recognized two classes of sites,
most of which were of high affinity (FH=71%); GMP-PNP progressively in-
creased KH, as expected for an allosteric interaction between two sites, without
affecting KL or FH. The effect of GMP-PNP in monomers required the presence
of DTT; the nucleotide-independent sites of low affinity may represent a sub-
population in which communication between the receptor- and ai1-domains has
been compromised. Only the oligomeric form of the fusion protein mimics the
behavior of GPCRs in natural membranes, suggesting that signaling in vivo pro-
ceeds via a stable complex comprising multiple equivalents of receptor and G
protein. (Supported by HSFO and CIHR)
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M2 muscarinic receptors were purified as monomers from Sf9 cells and recon-
stituted as monomers in nanodiscs and as tetramers in phospholipid vesicles. In
the absence of G proteins, monomers in solution and in nanodiscs appeared ho-
mogeneous (nH z 1), as revealed by the inhibitory effect of agonists and an-
tagonists on binding of the antagonist N-[3H]methylscopolamine.
Reconstituted tetramers appeared homogenous to antagonists (nH > 0.80)
and heterogeneous to agonists (nH < 0.80). The heterogeneity was modelled
as two classes of sites (log.IC50(High), log.IC50(Low)) and quantified as the
product of the difference in affinity (Dlog IC50) and the fraction of sites exhib-
iting higher affinity (FH) (i.e., FHDlog.IC50). The resulting values correlatedwith the corresponding values of FHDlog.IC50 and the intrinsic activities
reported previously for binding and response, respectively, in natural mem-
branes (p < 0.0001). In the presence of G proteins, reconstituted monomers
and tetramers exhibited sensitivity to the guanyl nucleotide GMP-PNP. With
tetramers, increasing concentrations of GMP-PNP caused an upward shift in
the binding profile of the agonist oxotremorine-M, an effect that emerged
from the model as an interconversion of labeled sites from high to low affinity
with little or no change in affinity per se. With monomers, increasing concen-
trations of GMP-PNP caused a lateral rightward shift that emerged as an
increase in the value of log.IC50. The vertical shift displayed by tetramers
mirrors the patterns observed previously in native membranes, while the lateral
shift displayed by monomers seems to be artefactual. This observation, taken
together with the correlation among agonists between efficacy and the
heterogeneity of reconstituted tetramers devoid of G protein, suggests that
oligomers—most likely tetramers—are the functional unit of the M2 musca-
rinic receptor in nature. (Supported by HSFO and CIHR)
136-Plat
Enhanced Conformational Sampling of M2 Muscarinic Acetylcholine
Receptor for Designing Selective Allosteric Drugs
Yinglong Miao1, J. Andrew McCammon1,2.
1Howard Hughes Medical Institute, La Jolla, CA, USA, 2University of
California, San Diego, La Jolla, CA, USA.
Muscarinic acetylcholine receptors are members of the superfamily of G-pro-
tein coupled receptors (GPCRs) and play critical roles in both the central and
parasympathetic nervous systems. They are important drug targets for the treat-
ment of a spectrum of diseases including abnormal heart rate, asthma, chronic
obstructive pulmonary disease, Alzheimer’s disease, Parkinson’s disease and
schizophrenia. Enhanced conformational sampling of M2 muscarinic receptor
is achieved via accelerated molecular dynamics (aMD) simulations. The simu-
lation output structures are clustered into representative conformers that are
structurally distinct from each other. Potential allosteric binding sites are
then identified by mapping the surface of the receptor conformers. This enables
virtual screening of chemical compounds against the allosteric binding sites to
discover receptor-selective drugs.
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All antipsychtics currently in clinical use are antagonists or weak partial ago-
nists at the dopamine D2 receptor (D2R). Antipsychotic medication is associ-
ated with adverse effects such as extrapyramidal symptoms (EPS). The lower
EPS liability of newer, so-called atypical antipsychotics, typified by clozapine,
has been proposed to reflect their faster rates of dissociation from the D2R, as
compared to older, typical antipsychotics such as haloperidol. This hypothesis
has received increasing attention in recent years, and several pharmaceutical
companies have endeavored to developed their own "fast off"-antipsychotics.
However, previous studies have measured dissociation of radiolabeled antipsy-
chotics or used modified G proteins to study receptor activation-induced cal-
cium release, which confers certain limitations in terms of temporal
resolution. We have examined antagonist dissociation in living cells, employ-
ing an assay based on the activation of G protein coupled potassium channels.
This assay uses native G proteins and has higher temporal resolution than pre-
vious studies.
Our preliminary data suggest that there may be larger differences between dif-
ferent atypical antipsychotics than has previously been appreciated. Further-
more, the differences between atypical and typical drugs appear to relate
mainly to the differential hydrophilicities of these drugs.
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Vision begins with the absorption of photons by rhodopsin, the visual pigment
in photoreceptors. Rhodopsin belongs to the family of G protein-coupled
receptors (GPCRs). Some family members form functional dimers or oligo-
mers. Whether rhodopsin forms oligomers and whether these oligomers are
functionally relevant is controversial 1-3. We study rhodopsin organization in
vitreous ultrathin cryo-sections of intact, dark-adapted photoreceptors by
